Kitazato

Kitazato Equity Turnover

The Equity Turnover of Kitazato (368A.T) as of Nov 17, 2026 is 0.56. In the previous year, Equity Turnover was 0.63 — a change of -10.06% (lower).

Equity Turnover

0.56

YoY

-10.06%

Last updated:

Equity Turnover of Kitazato is 2025 0.56 . Equity Turnover of Kitazato was 2024 0.63 . It decreases by -10.06% lower compared to the previous year.

The Kitazato Equity Turnover history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Turnover
Date
Equity Turnover
Jan 1, 2023
0.66 JPY
Jan 1, 2024
0.63 JPY
Jan 1, 2025
0.56 JPY
The Kitazato Equity Turnover history
YEAREquity TurnoverYoY
0.56-10.06%
0.63-5.42%
0.66—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Kitazato Stock analysis

What does Kitazato do? Kitazato Corp manufactures and sells medical devices, reagents, and related products for infertility treatment, specializing in reproductive engineering technology for artificial insemination, in vitro fertilization, and cell cryopreservation. The company produces consumables such as medical equipment and reagents used in in vitro fertilization and intracytoplasmic sperm injection, including media, cryo devices, medical devices, and micro tools. Kitazato Corp distributes its products globally, serving markets in Japan, Europe, the United States, China, and India, with a focus on research reagents and medical equipment for infertility treatment. The firm also manufactures and sells medical equipment parts, provides genetic testing services, and offers medical equipment for the elderly. Additionally, Kitazato Corp engages in market research, acquisition of local licenses, and contract management of living cells, expanding its reach into regenerative medicine and related fields. These services and products target healthcare providers, fertility clinics, and research institutions worldwide. Kitazato Corp's revenue streams include the sale of consumables, medical devices, and reagents, as well as genetic testing and contract management services. The company's global distribution network supports sales across key regions, with a strong emphasis on infertility treatment solutions and regenerative medicine technologies. Kitazato is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Kitazato stock

Equity Turnover of Kitazato is 0.56 in 2025.

Equity Turnover of Kitazato changed from 0.63 to 0.56, representing a -10.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Equity Turnover Kitazato since 2006 – with annual values, charts, and detailed analysis.

Equity turnover measures how efficiently a company uses shareholders' equity to generate revenue. It is a component of the DuPont analysis framework.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Turnover's Kitazato with sector peers and the industry average to assess whether it is attractive.

To evaluate Equity Turnover's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Equity Turnover.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Kitazato

All Key Metrics — Kitazato